======= USP27X ======= == Gene Information == * **Official Symbol**: USP27X * **Official Name**: ubiquitin specific peptidase 27 X-linked * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=389856|389856]] * **UniProt**: [[https://www.uniprot.org/uniprot/A6NNY8|A6NNY8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=USP27X&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20USP27X|Open PubMed]] * **OMIM**: [[https://omim.org/entry/300975|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the peptidase protein family. The encoded protein functions as a deubiquitinase that is involved in upregulation of the pro-apoptotic Bim protein. This protein may act as a tumor suppressor by increasing levels of Bim to counteract anti-apoptotic signals in cancer cells. Mutations in this gene have been associated with X-linked cognitive disability. [provided by RefSeq, Dec 2016]. * **UniProt Summary**: Deubiquitinase that can reduce the levels of BCL2L11/BIM ubiquitination and stabilize BCL2L11 in response to the RAF-MAPK- degradation signal. By acting on BCL2L11 levels, may counteract the anti-apoptotic effects of MAPK activity. {ECO:0000250|UniProtKB:Q8CEG8}. |UCH| |Lys63-specific deubiquitinase activity| |Lys48-specific deubiquitinase activity| |protein K63-linked deubiquitination| |protein K48-linked deubiquitination| |thiol-dependent ubiquitin-specific protease activity| |protein stabilization| |protein deubiquitination| |regulation of protein stability| |protein modification by small protein removal| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |protein catabolic process| |positive regulation of cell death| |cellular macromolecule catabolic process| |protein modification by small protein conjugation or removal| |macromolecule catabolic process| |organonitrogen compound catabolic process| |proteolysis| |regulation of apoptotic process| |regulation of programmed cell death| |regulation of cell death| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|-2.23| |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|-2.21| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|-1.96| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-1.83| |[[:results:exp487|Hinokiflavone 12μM R08 exp487]]|-1.73| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-1.72| |[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|1.72| |[[:results:exp336|Asunaprenir 3μM R07 exp336]]|1.74| |[[:results:exp536|Vitamin-D3 40μM R08 exp536]]|1.77| |[[:results:exp32|Rifampicin 10μM R00 exp32]]|1.82| |[[:results:exp222|Betulinic acid 10 to 15μM on day4 R05 exp222]]|1.9| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|1.96| |[[:results:exp346|CoCl2 18μM R07 exp346]]|1.98| |[[:results:exp360|Genistein 15μM R07 exp360]]|1.99| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|2.03| |[[:results:exp421|VHL-ligand-1 20μM R07 exp421]]|2.03| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|2.04| |[[:results:exp417|Tubastatin-A 2.5μM R07 exp417]]|2.09| |[[:results:exp185|L-BMAA 500 to 750μM on day4 R04 exp185]]|2.15| |[[:results:exp5|Alpha-Amanitin 0.5μM R00 exp5]]|2.2| |[[:results:exp486|Heregulin-B 44ng/ml R08 exp486]]|2.22| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|2.23| |[[:results:exp15|Cycloheximide 0.2μM R00 exp15]]|2.3| |[[:results:exp392|PT-1 25μM R07 exp392]]|2.37| |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|2.43| |[[:results:exp10|CCCP 0.1μM R00 exp10]]|2.52| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|2.53| |[[:results:exp496|Lead acetate 990μM R08 exp496]]|2.55| |[[:results:exp456|Benzoate 20000μM R08 exp456]]|2.72| |[[:results:exp4|Actinomycin-D 0.01μM R00 exp4]]|2.97| |[[:results:exp211|AICAR 240μM R05 exp211]]|3.22| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/694 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/26| |bone|0/26| |breast|0/30| |central nervous system|0/49| |cervix|0/4| |colorectal|0/17| |esophagus|0/11| |fibroblast|0/1| |gastric|0/14| |kidney|0/18| |liver|0/19| |lung|0/72| |lymphocyte|0/16| |ovary|0/25| |pancreas|0/22| |peripheral nervous system|0/15| |plasma cell|0/12| |prostate|0/1| |skin|0/20| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/28| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10925 * **Expression level (log2 read counts)**: 1.55 {{:chemogenomics:nalm6 dist.png?nolink |}}